Anti-tumor efficacy of a bevacizumab preconditioning followed by etoposide and cisplatin regimen in human epidermal growth factor receptor-2-positive breast cancer brain metastasis refractory to whole brain radiotherapy.
Saved in:
| Title: | Anti-tumor efficacy of a bevacizumab preconditioning followed by etoposide and cisplatin regimen in human epidermal growth factor receptor-2-positive breast cancer brain metastasis refractory to whole brain radiotherapy. |
|---|---|
| Authors: | Chen, Tom1, Lin, Ching-Hung2, Yeh, Dah-Cherng3, Tseng, Ling-Ming4, Rau, Kun-Ming5, Chen, Bang-Bin6, Chao, Ta-Chung7, Huang, Shu-Min8, Chang, Dwan-Ying9, Chen, I-Chun1, Cheng, Ann-Lii10, Lu, Yen-Shen2 |
| Source: | Journal of Cancer Research & Practice. Jan-Mar2023, Vol. 10 Issue 1, p11-18. 8p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 23113006 |
|---|---|
| DOI: | 10.4103/ejcrp.eJCRP-D-23-00001 |
